Early Detection and Intervention for the Prevention of Psychosis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- William R. McFarlane, M.D.
MaineHealth
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California-Davis, Imaging Research Center
Sacramento, California, United States
- Portland Identification and Early Referral Program
Portland, Maine, United States
- Washtenaw County
Ann Arbor, Michigan, United States
- University of New Mexico
Albuquerque, New Mexico, United States
- Zucker Hillside Hosptial
Glen Oaks, New York, United States
- Mid-Valley Behavioral Care Network
Salem, Oregon, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2007
- Primary completion
- 31 May 2013
- Completion
- 30 Sept 2013
- Last update posted
- 15 Aug 2016
- Registered enrollment
- 292
- Registry id
- NCT00531518
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.